1996
DOI: 10.1002/(sici)1097-0215(19960529)66:5<711::aid-ijc21>3.0.co;2-5
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong

Abstract: Prevalence of LMPl deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong KongChang et al. (1995) have described a prevalent strain of Epstein-Burr virus (EBV) associated with T-cell lymphoma and nasopha yngeal carcinoma (NPC) in the Taiwanesepopulation. The strain was identical to a previously reported NPC-EBV strain from a cell line -1510 originating from Taiwan, which showed Xho I restriction enzyme polymorphism in exon 1 and a 30-bp deletion in exon 3 of the latent … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
35
0

Year Published

1997
1997
2017
2017

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 57 publications
(40 citation statements)
references
References 2 publications
5
35
0
Order By: Relevance
“…However, the different strains of LMP1 and experimental approaches used in the two studies may also be accountable for the discrepancy observed in the action of LMP1 on Glut-1 transcription. In our study, the 2117-LMP1 used is the common LMP1 variant detected in nasopharyngeal carcinoma (NPC) from Hong Kong patients (33). The 2117-LMP1 was reported to have more potent activity in NF-B activation but lower cellular toxicity than the B95.8-derived LMP1 sequences commonly used in B cell lymphoma studies (34).…”
Section: Discussionmentioning
confidence: 92%
“…However, the different strains of LMP1 and experimental approaches used in the two studies may also be accountable for the discrepancy observed in the action of LMP1 on Glut-1 transcription. In our study, the 2117-LMP1 used is the common LMP1 variant detected in nasopharyngeal carcinoma (NPC) from Hong Kong patients (33). The 2117-LMP1 was reported to have more potent activity in NF-B activation but lower cellular toxicity than the B95.8-derived LMP1 sequences commonly used in B cell lymphoma studies (34).…”
Section: Discussionmentioning
confidence: 92%
“…Most LMP1 genes derived from Chinese NPC biopsy specimens are marked by the 30-bp deletion (nt 168266 to 168295) in the carboxyl terminus, a loss of the XhoI site in the amino terminus, and multiple base substitutions in the coding region (9,10,22,25). Although the 30-bp deletion in LMP1 was detected in 100% of 48 NPC biopsy specimens in Taiwan (8), in 34 of 37 NPC biopsy specimens in Hong Kong (11), and in 16 of 21 NPC biopsy specimens in Guangxi and Shanghai (51), Zhang et al (56) reported that the 30-bp deletion in LMP1 represents a geographical-or race-associated polymorphism rather than an NPC disease phenotype-associated polymorphism. Recently, the consistent sequence variation in LMP1 has been used to distinguish the various EBV strains, which were termed strains China 1, China 2, Med, China3, Alaskan, NC, and B95.8.…”
Section: Discussionmentioning
confidence: 99%
“…The 30-bp deletion, detected also in a proportion of Alaska native, Caucasian (125,126), Malaysian (122), and North African NPC (127,128), seems to enhance the transforming potential of LMP1 in vitro, and may be present in more aggressive disease forms (117,(129)(130)(131). However, there is no strong evidence that the deleted variant is associated with increased risk of NPC (120,123,132,133), and there is a lack of large, well-designed epidemiologic studies of risk associations with EBV variants. Furthermore, the detection of specific LMP1 mutations in NPC tumors from diverse regions suggests that EBV strain variation is not geographically correlated with NPC incidence.…”
Section: Risk Factorsmentioning
confidence: 99%